The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus
- PMID: 33350025
- PMCID: PMC7537046
- DOI: 10.1002/rmv.2171
The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus
Abstract
From 2002 to 2019, three deadly human coronaviruses (hCoVs), severe acute respiratory syndrome coronavirus (SARS-CoV), Middle Eastern respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged to produce outbreaks of SARS, MERS and coronavirus disease 2019 (Covid-19), respectively. All three hCoVs are members of the Betacoronavirus genus in the subfamily Orthocoronavirinae and share many similarities in virology and epidemiology. However, the pattern and scale of Covid-19 global spread is similar to 2009 pandemic H1N1 influenza (H1N1pdm09), rather than SARS or MERS. Covid-19 exhibits high viral shedding in the upper respiratory tract at an early stage of infection, and has a high proportion of transmission competent individuals that are pre-symptomatic, asymptomatic and mildly symptomatic, characteristics seen in H1N1pdm09 but not in SARS or MERS. These two traits of Covid-19 and H1N1pdm09 result in reduced efficiency in identification of transmission sources by symptomatic screening and play important roles in their ability to spread unchecked to cause pandemics. To overcome these attributes of Covid-19 in community transmission, identifying the transmission source by testing for virus shedding and interrupting chains of transmission by social distancing and public masking are required.
Keywords: Covid-19; MERS; SARS; pandemic influenza; pre-symptomatic infection; viral shedding.
© 2020 John Wiley & Sons Ltd.
Conflict of interest statement
All the authors declare that there is no existing commercial or financial conflict of interest, in any way.
Figures

Similar articles
-
Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.Front Immunol. 2020 Sep 11;11:552909. doi: 10.3389/fimmu.2020.552909. eCollection 2020. Front Immunol. 2020. PMID: 33013925 Free PMC article. Review.
-
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.Elife. 2021 Apr 16;10:e65774. doi: 10.7554/eLife.65774. Elife. 2021. PMID: 33861198 Free PMC article.
-
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.Respir Res. 2020 Aug 27;21(1):224. doi: 10.1186/s12931-020-01479-w. Respir Res. 2020. PMID: 32854739 Free PMC article.
-
[Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV].Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):511-516. doi: 10.3760/cma.j.cn112151-20200301-00155. Zhonghua Bing Li Xue Za Zhi. 2020. PMID: 32392945 Chinese.
-
Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?Biomolecules. 2020 Sep 11;10(9):1312. doi: 10.3390/biom10091312. Biomolecules. 2020. PMID: 32933047 Free PMC article. Review.
Cited by
-
Analysis of COVID-19 pandemics in Kazakhstan.J Res Health Sci. 2021 May 26;21(2):e00512. doi: 10.34172/jrhs.2021.52. J Res Health Sci. 2021. PMID: 34465636 Free PMC article.
-
Virus Inactivation Based on Optimal Surfactant Reservoir of Mesoporous Silica.ACS Appl Bio Mater. 2023 Mar 20;6(3):1032-1040. doi: 10.1021/acsabm.2c00901. Epub 2023 Feb 13. ACS Appl Bio Mater. 2023. PMID: 36780326 Free PMC article.
-
Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies.Viruses. 2021 Jun 15;13(6):1145. doi: 10.3390/v13061145. Viruses. 2021. PMID: 34203647 Free PMC article. Review.
-
Comparative analysis of inflight transmission of SARS-CoV-2, influenza, and SARS-CoV-1.Epidemiol Infect. 2023 Jun 23;151:e111. doi: 10.1017/S0950268823001012. Epidemiol Infect. 2023. PMID: 37350245 Free PMC article.
-
Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities.Med Rev (2021). 2022 Apr 26;2(2):169-196. doi: 10.1515/mr-2021-0021. Epub 2022 May 25. Med Rev (2021). 2022. PMID: 35862507 Free PMC article. Review.
References
-
- WHO . Middle East respiratory syndrome coronavirus (MERS‐CoV) – Qatar 2020. https://www.who.int/csr/don/12-march-2020-mers-qatar/en/. Accessed 30 March 2020.
-
- WHO . Coronavirus disease 2019 (COVID‐19) situation report – 72 [Organization website]. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed 30 July, 2020.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous